Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - GPR - MEDICA16

MEDICA16

CAS No. 87272-20-6

MEDICA16( MEDICA 16 )

Catalog No. M27653 CAS No. 87272-20-6

MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 Get Quote
10MG 132 Get Quote
25MG 282 Get Quote
50MG 484 Get Quote
100MG 700 Get Quote
500MG 1458 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    MEDICA16
  • Note
    Research use only, not for human use.
  • Brief Description
    MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120.
  • Description
    MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120. MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle with an increase in insulin sensitivity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MEDICA 16
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    PHD3|HIF-2α|VEGFR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    87272-20-6
  • Formula Weight
    342.52
  • Molecular Formula
    C20H38O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (291.96 mM)
  • SMILES
    CC(C)(CCCCCCCCCCC(C)(C)CC(O)=O)CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Roda JM, et al. Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model. J Immunol. 2012 Sep 15;189(6):3168-77.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • YE 120

    YE 120 is a highly potent GPR35 agonist (EC50: 32.5 nM) with potential anti-inflammatory and anti-cancer activities, which can be used to study G protein-coupled receptor-related diseases.

  • MBX2982

    MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.

  • BigLEN (rat)

    Potent GPR171 agonist (EC50 = 1.6 nM). ProSAAS-derived peptide. Regulates body weight in mice and promotes the outgrowth of neurites in Neuro2A cells.

Sign In Join Free